Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00436709
Information provided by National Cancer Institute (NCI)
First Received: February 15, 2007
Last Updated: March 11, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
